Andrew Stark is a Neurodivergent Process Chemist with experience at AstraZeneca since graduation. After spending 15 years in the lab as an Associate Principal Scientist, Andrew transitioned to technical outsourcing, collaborating with external partners to develop drug substances for Tox studies and Phase I/II trials. Passionate about sustainability in drug development, they focus on scaling up innovative reactions and equipment to support the #CarbonZero initiative. Additionally, Andrew actively engages in STEM advocacy, hosting work experience events to mentor pupils in exploring careers in the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices